702800002: Alogliptin benzoate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Substance with enzyme inhibitor mechanism of action\Substance with hydrolase inhibitor mechanism of action\Substance with peptide hydrolase inhibitor mechanism of action\Substance with dipeptidyl peptidase IV inhibitor mechanism of action\Alogliptin benzoate

\Drug or medicament\Alogliptin benzoate

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\...

\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate

\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Pyrimidine\Alogliptin benzoate
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Alogliptin benzoate

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3006159012 Alogliptin benzoate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3006161015 Alogliptin benzoate en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Alogliptin benzoate	Is a	Alogliptin	false	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Has disposition	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Substance with dipeptidyl peptidase IV inhibitor mechanism of action	true	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is modification of	Alogliptin	true	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Chemical categorized functionally	false	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Substance with enzyme inhibitor mechanism of action	false	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Pyrimidine	true	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Piperidine	true	Inferred relationship	Existential restriction modifier
Alogliptin benzoate	Is a	Drug or medicament	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has basis of strength substance	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has basis of strength substance	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has basis of strength substance	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet	Has precise active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin (as alogliptin benzoate) 6.25 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	1
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier	2
Vipidia 12.5mg tablets (Ethigen Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Ethigen Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Pharmaram Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Pharmaram Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Pharmaram Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Pharmaram Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (CST Pharma Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (CST Pharma Ltd) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (CST Pharma Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (DE Pharmaceuticals) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (DE Pharmaceuticals) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (DE Pharmaceuticals) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (DE Pharmaceuticals) 56 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (DE Pharmaceuticals)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Ethigen Ltd) 56 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Ethigen Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Takeda UK Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets 56 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd) 56 tablet 4 x 14 tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Takeda UK Ltd)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Waymade Healthcare Plc)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Waymade Healthcare Plc)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Waymade Healthcare Plc)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipdomet 12.5mg/1000mg tablets (Waymade Healthcare Plc) 56 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 12.5mg tablets (Waymade Healthcare Plc) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 25mg tablets (Waymade Healthcare Plc) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (Ennogen Healthcare Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Ennogen Healthcare Ltd) 56 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Ennogen Healthcare Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Ennogen Healthcare Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (Ennogen Healthcare Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (J M McGill Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (J M McGill Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (J M McGill Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (J M McGill Ltd) 56 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (J M McGill Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (J M McGill Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (J M McGill Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Niche Pharma Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Niche Pharma Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Niche Pharma Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (Niche Pharma Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Niche Pharma Ltd) 56 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Niche Pharma Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Niche Pharma Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 6.25mg tablets (Niche Pharma Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Colorama Pharmaceuticals Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Colorama Pharmaceuticals Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Colorama Pharmaceuticals Ltd)	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg / Metformin 1g tablets (Colorama Pharmaceuticals Ltd) 56 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 12.5mg tablets (Colorama Pharmaceuticals Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Alogliptin 25mg tablets (Colorama Pharmaceuticals Ltd) 28 tablet	Has specific active ingredient	False	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Originalis B.V.)	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier
Vipidia 6.25mg tablets (Originalis B.V.) 28 tablet	Has specific active ingredient	True	Alogliptin benzoate	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3006159012	Alogliptin benzoate (substance)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3006161015	Alogliptin benzoate	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module